×
For best experience we recommend to activate Javascript in your browser.
CD57 antibody (AA 28-334)
This anti-CD57 antibody is a Mouse Monoclonal antibody detecting CD57 in IHC, WB, IP and ICC. Suitable for Human.
Quick Overview for CD57 antibody (AA 28-334) (ABIN7612743)
Target
See all CD57 (B3GAT1) Antibodies
CD57 (B3GAT1)
(beta-1,3-Glucuronyltransferase 1 (Glucuronosyltransferase P) (B3GAT1))
Reactivity
All reactivities for CD57 antibodies
Human
Host
All hosts for CD57 antibodies
Mouse
Clonality
All clonalities for CD57 antibodies
Monoclonal
Conjugate
All conjugates for CD57 antibodies
This CD57 antibody is un-conjugated
Application
All applications for CD57 antibodies
Immunohistochemistry (IHC), Western Blotting (WB), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Clone
C2
Product Details anti-CD57 Antibody
(hide)
Binding Specificity
All epitopes for CD57 antibodies
AA 28-334
Purpose
Beta-1,3-Glucuronyltransferase 1 (b3GAT1) Monoclonal Antibody
Sequence
Thr28~Ile334
Characteristics
The Beta-1,3-Glucuronyltransferase 1 (b3GAT1) Monoclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Protein A + Protein G affinity chromatography
Isotype
IgG1 kappa
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for CD57
(hide)
Target
CD57 (B3GAT1)
(beta-1,3-Glucuronyltransferase 1 (Glucuronosyltransferase P) (B3GAT1))
Alternative Name
b3GAT1
Gene ID
27087
UniProt
Q9P2W7
Pathways
Glycosaminoglycan Metabolic Process
Recently viewed
(hide)
Chat with us , powered by LiveChat